Form D · Pharmaceuticals
GPI Finco (Canada) Inc.
Lansing, MI · CIK 0001770912
Offering snapshot reported Mar 19, 2019 · SEC filing
- Reported sold
- $22.9M Offering amount: $22.9M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2019 | Initial | $22,880,000 | No comparison | 49 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.19M
- Finders' fees
- $0
- Form D file number
- 021-335223
Series A Convertible Debentures and underlying Series A shares
In addition to the cash commission, the agents received 1,602 agent warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Canaccord Genuity Corp. | None | Canaccord Genuity LLC · CRD 1020 |
| Beacon Securities Limited | None | Canaccord Genuity LLC · CRD 1020 |
Source: Form D, filed Mar 19, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Donahue | Executive |
| Jeff Radway | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1669 E. Jolly Road
Lansing, MI, 48910
Lansing, MI, 48910